PREPlab

Stop PREP to stop neurodegeneration?

We are studying the role of prolyl oligopeptidase (PREP, formerly known as POP) on disease progression and neuronal toxicity in neurodegenerative disorders with protein aggregation. These disorders involve several serious diseases such as Alzheimer’s and Parkinson’s diseases, and several more rare neurodegenerative conditions. Based on PREP inhibitors, we are developing novel and disease-modifying drug therapies to stop the neuronal death in Alzheimer's and Parkinson's diseases.
Find more about PREP research

News

Recent news from PREP lab
@PREPresearch

Happy to share our study which shows protein synthesis is reduced in skin cells from #Parkinson’s patients. Lower p… twitter.com/i/web/status/1…

Researchers from @aboakademi & @UniTurku (led by @CoffeyLabFi) report that protein synthesis is suppressed in famil… twitter.com/i/web/status/1…

Interested in #CDNF 12-month data in #Parkinsons? Register to our webinar held tomorrow at 15–16 CET: herantis.com/press_releases…

Welcome to the Innovation in Neuroscience online seminar on 21.9.2020 organised by @hnbrainmind, a neuroscience hub… twitter.com/i/web/status/1…